No profile data available.
ViaDerma, Inc. (VDRM) is a healthcare company in the antibacterial pharmaceuticals industry, based in Las Vegas, United States.
It reported revenue of $19.01 million for fiscal year 2011, down 29.2% from fiscal year 2010, and net income of $2.67 million. In Q2 2012 (the quarter ended June 30, 2012) revenue was $5.82 million, up 0.2% from a year before. Its market capitalization was $123,371 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2011; market data as of October 8, 2026.
, through its subsidiary, manufactures and sells pharmaceutical related products in the United States. The company's lead product is Vitastem, a tetracycline and topical delivery technology for antibiotics to pain relief, skincare, and other.
ViaDerma reported $19.01 million in revenue for fiscal year 2011, down 29.2% from $26.83 million in fiscal year 2010. In Q2 2012 revenue was $5.82 million.
$123,371 as of October 8, 2026.
Listed companies of a similar size in the same industry (antibacterial pharmaceuticals) include Acurx Pharmaceuticals, Inc. (ACXP), BiomX Inc. (PHGE), RedHill Biopharma Ltd. (RDHL).